Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer

NCT01829113 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

OTHER

Sponsor class

Conditions

Non Squamous Non Small Cell Lung Cancer

Interventions

DRUG: OGX-427
DRUG: Placebo

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]